Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 2/20 | 0.68 |
| ▸ | MIF | P14174 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | SCN4A | P35499 | 1/20 | 0.59 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | ESRRG | P62508 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12641934 | 0.84 | GFER (0.72) | GFERMIFKMT2AGAAMEN1 | |
| SCHEMBL15718835 | 0.83 | KMT2A (0.63) | GFERKMT2AGAAMEN1SMN1; SMN2 | |
| SCHEMBL17560984 | 0.83 | SCN4A (0.82) | GFERKMT2AGAAMEN1SMN1; SMN2 | |
| SCHEMBL17560986 | 0.83 | SCN4A (0.82) | GFERKMT2AGAAMEN1SMN1; SMN2 | |
| SCHEMBL15718834 | 0.83 | KMT2A (0.63) | GFERKMT2AGAAMEN1SMN1; SMN2 | |
| SCHEMBL24000970 | 0.83 | KMT2A (0.71) | GFERKMT2AGAAMEN1SMN1; SMN2 | |
| SCHEMBL17560884 | 0.83 | PRMT5 (0.61) | GFERKMT2AGAAMEN1SMN1; SMN2 | |
| SCHEMBL17560882 | 0.83 | PRMT5 (0.61) | GFERKMT2AGAAMEN1SMN1; SMN2 | |
| Phenylsemicarbazone SCHEMBL11882629 | 0.82 | MEN1 (0.71) | GFERKMT2AGAAMEN1SMN1; SMN2 | |
| Phenylsemicarbazone SCHEMBL9018897 | 0.82 | MEN1 (0.71) | GFERKMT2AGAAMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11565995-B2 | Methods of forming imines, imine-related and imine-derived compounds using green solvents | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11565995-B2 | Methods of forming imines, imine-related and imine-derived compounds using green solvents | IK, LDHB, IDH3B | GFER 2269/4885MIF 83/4885KMT2A 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.